Table 3.
FoxP3-Positive T Cells, % |
|||
---|---|---|---|
Patient | Diagnosis | Epidermis | Dermis |
1 | AD | 15 | 20 |
2 | SAD | 20 | 30 |
3 | SAD | 25 | 40 |
4 | SAD | 35 | 40 |
5 | SAD | 20 | 30 |
6 | SAD | 25 | 45 |
7 | SAD | 30 | 20 |
8 | SAD | 15 | 10 |
9 | SAD | 20 | 45 |
10 | SAD | 15 | 25 |
11 | SAD | 15 | 25 |
12 | Fixed drug | 10 | 20 |
13 | GVHD | 5 | 15 |
14 | GVHD | 5 | 10 |
15 | LE | 5 | 15 |
16 | LE | 35 | 25 |
17 | LE | 25 | 30 |
18 | LP | 25 | 10 |
19 | LP | 25 | 25 |
20 | LAK | 30 | 30 |
21 | BLK | 15 | 15 |
22 | BLK | 55 | 35 |
Abbreviations: AD, acute dermatitis, acute spongiotic dermatitis; BLK, benign lichenoid keratosis; GVHD, graft- vs-host disease; LAK, lichenoid actinic keratosis; LE, lupus erythematosus; LP, lichen planus; NA, not applicable; SAD, subacute dermatitis, subacute spongiotic dermatitis.